Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients
Background. Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women of reproductive age, whose clinical characteristics are hyperandrogenism (HA), ovulatory dysfunction, and polycystic ovary, often accompanied by insulin resistance (IR) and metabolic abnormalities. Glucagon-li...
Saved in:
Main Authors: | Jingwen Gan, Jie Chen, Rui-lin Ma, Yan Deng, Xue-song Ding, Shi-yang Zhu, Ai-jun Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2023/4288004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
by: Xuan Du, et al.
Published: (2018-01-01) -
The combined effect of metformin and mirabegron on diet‐induced obesity
by: Xin‐Yuan Zhao, et al.
Published: (2023-04-01) -
Metformin dosage and galectin-3 levels: insights from PCOS patients preparing for IVF
by: Valentina N. Nikolić, et al.
Published: (2025-01-01) -
Effects Of Metformin And Myo-Inositol In Combination Versus Metformin As Monotherapy On The Metabolic Profile Of Polycystic Ovarian Syndrome Patients With Infertility
by: Hira Ehsan Khattak, et al.
Published: (2024-09-01) -
PLEYOTROPIC EFFECTS OF METFORMIN
by: L. Ju. Morgunov
Published: (2015-01-01)